554 related articles for article (PubMed ID: 22874761)
21. The anion transporter SLC26A9 localizes to tight junctions and is degraded by the proteasome when co-expressed with F508del-CFTR.
Sato Y; Thomas DY; Hanrahan JW
J Biol Chem; 2019 Nov; 294(48):18269-18284. PubMed ID: 31645438
[TBL] [Abstract][Full Text] [Related]
22. HGF stimulation of Rac1 signaling enhances pharmacological correction of the most prevalent cystic fibrosis mutant F508del-CFTR.
Moniz S; Sousa M; Moraes BJ; Mendes AI; Palma M; Barreto C; Fragata JI; Amaral MD; Matos P
ACS Chem Biol; 2013 Feb; 8(2):432-42. PubMed ID: 23148778
[TBL] [Abstract][Full Text] [Related]
23. Parallel improvement of sodium and chloride transport defects by miglustat (n-butyldeoxynojyrimicin) in cystic fibrosis epithelial cells.
Noël S; Wilke M; Bot AG; De Jonge HR; Becq F
J Pharmacol Exp Ther; 2008 Jun; 325(3):1016-23. PubMed ID: 18309088
[TBL] [Abstract][Full Text] [Related]
24. Steviol reduces MDCK Cyst formation and growth by inhibiting CFTR channel activity and promoting proteasome-mediated CFTR degradation.
Yuajit C; Homvisasevongsa S; Chatsudthipong L; Soodvilai S; Muanprasat C; Chatsudthipong V
PLoS One; 2013; 8(3):e58871. PubMed ID: 23536832
[TBL] [Abstract][Full Text] [Related]
25. Potentiation of cystic fibrosis transmembrane conductance regulator (CFTR) Cl- currents by the chemical solvent tetrahydrofuran.
Hughes LK; Ju M; Sheppard DN
Mol Membr Biol; 2008 Sep; 25(6-7):528-38. PubMed ID: 18989824
[TBL] [Abstract][Full Text] [Related]
26. Aggregates of mutant CFTR fragments in airway epithelial cells of CF lungs: new pathologic observations.
Du K; Karp PH; Ackerley C; Zabner J; Keshavjee S; Cutz E; Yeger H
J Cyst Fibros; 2015 Mar; 14(2):182-93. PubMed ID: 25453871
[TBL] [Abstract][Full Text] [Related]
27. Proteasome-dependent pharmacological rescue of cystic fibrosis transmembrane conductance regulator revealed by mutation of glycine 622.
Norez C; Bilan F; Kitzis A; Mettey Y; Becq F
J Pharmacol Exp Ther; 2008 Apr; 325(1):89-99. PubMed ID: 18230692
[TBL] [Abstract][Full Text] [Related]
28. Deletion of Phe508 in the first nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator increases its affinity for the heat shock cognate 70 chaperone.
Scott-Ward TS; Amaral MD
FEBS J; 2009 Dec; 276(23):7097-109. PubMed ID: 19878303
[TBL] [Abstract][Full Text] [Related]
29. miR-16 rescues F508del-CFTR function in native cystic fibrosis epithelial cells.
Kumar P; Bhattacharyya S; Peters KW; Glover ML; Sen A; Cox RT; Kundu S; Caohuy H; Frizzell RA; Pollard HB; Biswas R
Gene Ther; 2015 Nov; 22(11):908-16. PubMed ID: 26133785
[TBL] [Abstract][Full Text] [Related]
30. Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis.
Ramalho AS; Beck S; Meyer M; Penque D; Cutting GR; Amaral MD
Am J Respir Cell Mol Biol; 2002 Nov; 27(5):619-27. PubMed ID: 12397022
[TBL] [Abstract][Full Text] [Related]
31. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients.
Dray-Charier N; Paul A; Scoazec JY; Veissière D; Mergey M; Capeau J; Soubrane O; Housset C
Hepatology; 1999 Jun; 29(6):1624-34. PubMed ID: 10347100
[TBL] [Abstract][Full Text] [Related]
32. Activation of farnesoid X receptor retards expansion of renal collecting duct cell-derived cysts via inhibition of CFTR-mediated Cl
Srimai N; Tonum K; Soodvilai S
Am J Physiol Renal Physiol; 2024 Apr; 326(4):F600-F610. PubMed ID: 38299213
[TBL] [Abstract][Full Text] [Related]
33. Probing conformational rescue induced by a chemical corrector of F508del-cystic fibrosis transmembrane conductance regulator (CFTR) mutant.
Yu W; Kim Chiaw P; Bear CE
J Biol Chem; 2011 Jul; 286(28):24714-25. PubMed ID: 21602569
[TBL] [Abstract][Full Text] [Related]
34. CFTR: a hub for kinases and crosstalk of cAMP and Ca2+.
Kunzelmann K; Mehta A
FEBS J; 2013 Sep; 280(18):4417-29. PubMed ID: 23895508
[TBL] [Abstract][Full Text] [Related]
35. Discovery of pyrrolo[2,3-b]pyrazines derivatives as submicromolar affinity activators of wild type, G551D, and F508del cystic fibrosis transmembrane conductance regulator chloride channels.
Noel S; Faveau C; Norez C; Rogier C; Mettey Y; Becq F
J Pharmacol Exp Ther; 2006 Oct; 319(1):349-59. PubMed ID: 16829626
[TBL] [Abstract][Full Text] [Related]
36. Osteoclastogenesis and sphingosine-1-phosphate secretion from human osteoclast precursor monocytes are modulated by the cystic fibrosis transmembrane conductance regulator.
Jourdain ML; Sergheraert J; Braux J; Guillaume C; Gangloff SC; Hubert D; Velard F; Jacquot J
Biochim Biophys Acta Mol Basis Dis; 2021 Mar; 1867(3):166010. PubMed ID: 33188942
[TBL] [Abstract][Full Text] [Related]
37. Discovery of alpha-aminoazaheterocycle-methylglyoxal adducts as a new class of high-affinity inhibitors of cystic fibrosis transmembrane conductance regulator chloride channels.
Routaboul C; Norez C; Melin P; Molina MC; Boucherle B; Bossard F; Noel S; Robert R; Gauthier C; Becq F; Décout JL
J Pharmacol Exp Ther; 2007 Sep; 322(3):1023-35. PubMed ID: 17578899
[TBL] [Abstract][Full Text] [Related]
38. Insights into the mechanisms underlying CFTR channel activity, the molecular basis for cystic fibrosis and strategies for therapy.
Kim Chiaw P; Eckford PD; Bear CE
Essays Biochem; 2011 Sep; 50(1):233-48. PubMed ID: 21967060
[TBL] [Abstract][Full Text] [Related]
39. [Inhibitors of intra-cystic secretion: novel therapies in ADPKD (Autosomal Dominant Polycystic Kidney Disease)].
Miranda N; Miranda F; Rinaldi L; Stratigis S; Capasso G
G Ital Nefrol; 2013; 30(1):. PubMed ID: 23832438
[TBL] [Abstract][Full Text] [Related]
40. Direct interaction of a small-molecule modulator with G551D-CFTR, a cystic fibrosis-causing mutation associated with severe disease.
Pasyk S; Li C; Ramjeesingh M; Bear CE
Biochem J; 2009 Feb; 418(1):185-90. PubMed ID: 18945216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
